The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 4-11 , October 2006

The Value of Forced Expiratory Volume in 1 Second Decline in the Assessment of Chronic Obstructive Pulmonary Disease Progression

  • Robert A. Wise, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Robert A. Wise, MD, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, Maryland 21224.

References 

  1. Fletcher C , Peto R . The natural history of chronic airflow obstruction . BMJ . 1977;1:1645–1648
  2. Scanlon PD , Connett JE , Waller LA , Altose MD , Bailey WC , Buist AS . Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study . Am J Respir Crit Care Med . 2000;161:381–390
  3. Decramer M , Gosselink R , Rutten-Van Molken M , et al.  Assessment of progression of COPD: report of a workshop held in Leuven, 11–12 March 2004 . Thorax . 2005;60:335–342
  4. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease—Updated 2003 . Bethesda, MD: US Dept of Health and Human Services, National Institutes of Health; 2004;
  5. Stratelis G , Jakobsson P , Molstad S , Zetterstrom O . Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years . Br J Gen Pract . 2004;54:201–206
  6. Lundback B , Lindberg A , Lindstrom M , et al.  Obstructive Lung Disease in Northern Sweden [OLIN] Studies investigators   Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies . Respir Med . 2003;97:115–122
  7. Anthonisen NR , Connett JE , Kiley JP , et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study . JAMA . 1994;272:1497–1505
  8. Anthonisen NR , Connett JE , Murray RP . Smoking and lung function of Lung Health Study participants after 11 years . Am J Respir Crit Care Med . 2002;166:675–679
  9. Simmons MS , Connett JE , Nides MA , et al.  Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study . Eur Respir J . 2005;25:1011–1017
  10. O’Donnell DE , Revill SM , Webb KA . Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2001;164:770–777
  11. Sciurba F , Criner GJ , Lee SM , et al.  National Emphysema Treatment Trial Research Group   Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length . Am J Respir Crit Care Med . 2003;167:1522–1527
  12. Ketelaars CA , Schlosser MA , Mostert R , Huyer Abu-Saad H , Halfens RJ , Wouters EF . Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease . Thorax . 1996;51:39–43
  13. Stahl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes [serial online]. 2005;3:56. Available at: http://www.hqlo.com/content/3/1/56. Accessed on August 22, 2006.
  14. Antonelli-Incalzi R , Imperiale C , Bellia V , et al.  Do GOLD stages of COPD severity really correspond to differences in health status? . Eur Respir J . 2003;22:444–449
  15. Brown CD, Rand CS, Connett JE, Wise RA. The effect of lung function and gender on quality of life in COPD [Abstract]. Presented at the American Thoracic Society International Meeting; May 19–24, 2006; San Diego, California. Available at: http://www.abstract2view.com/ats06/view.php?nu=ATS06L_516. Accessed August 22, 2006.
  16. Ferrer M , Villasante C , Alonso J , et al.  Interpretation of quality of life scores from the St George’s Respiratory Questionnaire . Eur Respir J . 2002;19:405–413
  17. Cullen K , Stenhouse NS , Wearne KL , Welborn TA . Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia—13-year study . J Chronic Dis . 1983;36:371–377
  18. Peto R , Speizer FE , Cochrane AL , et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation . Am Rev Respir Dis . 1983;128:491–500
  19. Ebi-Kryston KL . Predicting 15 year chronic bronchitis mortality in the Whitehall Study . J Epidemiol Community Health . 1989;43:168–172
  20. Kuller LH , Ockene J , Meilahn E , Svendsen KH . Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT) . Am J Epidemiol . 1990;132:265–274
  21. Bang KM , Gergen PJ , Kramer R , Cohen B . The effect of pulmonary impairment on all-cause mortality in a national cohort . Chest . 1993;103:536–540
  22. Hole DJ , Watt GC , Davey-Smith G , Hart CL , Gillis CR , Hawthorne VM . Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study . BMJ . 1996;313:711–715
  23. Anthonisen NR , Skeans MA , Wise RA , Manfreda J , Kanner RE , Connett JE . The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial . Ann Intern Med . 2005;142:233–239
  24. Rodriguez BL , Masaki K , Burchfiel C , et al.  Pulmonary function decline and 17-year total mortality: the Honolulu Heart Program . Am J Epidemiol . 1994;140:398–408
  25. Ryan G , Knuiman MW , Divitini ML , James A , Musk AW , Bartholomew HC . Decline in lung function and mortality: the Busselton Health Study . J Epidemiol Community Health . 1999;53:230–234
  26. Burchfiel CM , Marcus EB , Sharp DS , et al.  Characteristics associated with rapid decline in forced expiratory volume . Ann Epidemiol . 1996;6:217–227
  27. Anto JM , Vermeire P , Vestbo J , Sunyer J . Epidemiology of chronic obstructive pulmonary disease . Eur Respir J . 2001;17:982–994
  28. Burrows B , Knudson RJ , Camilli AE , Lyle SK , Lebowitz MD . The “horse-racing effect” and predicting decline in forced expiratory volume in one second from screening spirometry . Am Rev Respir Dis . 1987;135:788–793
  29. Enright RL , Connett JE , Bailey WC . The FEV1/FEV6 predicts lung function decline in adult smokers . Respir Med . 2002;96:444–449
  30. Tashkin DP , Altose MD , Connett JE , Kanner RE , Lee WW , Wise RA  Lung Health Study Research Group . Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 1996;153:1802–1811
  31. Donaldson GC , Seemungal TA , Bhowmik A , Wedzicha JA . Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease . Thorax . 2002;57:847–852
  32. Kanner RE , Anthonisen NR , Connett JE . Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study . Am J Respir Crit Care Med . 2001;164:358–364
  33. Kanazawa H , Hirata K , Yoshikawa J . Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients . Chest . 2003;123:596–599
  34. Vergnenegre A , Pugnere N , Antonini MT , et al.  Airway obstruction and rheumatoid arthritis . Eur Respir J . 1997;10:1072–1078
  35. Sutherland ER , Allmers H , Ayas NT , Venn AJ , Martin RJ . Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis . Thorax . 2003;58:937–941
  36. Highland KB , Strange C , Heffner JE . Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease: a meta-analysis . Ann Intern Med . 2003;138:969–973
  37. Decramer M , Rutten-van Molken M , Dekhuijzen PN , et al.  Effects of n-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial . Lancet . 2005;365:1552–1560
  38. Sandford AJ , Silverman EK . Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD: the genotype-environment interaction . Thorax . 2002;57:736–741
  39. van Diemen CC , Postma DS , Vonk JM , Bruinenberg M , Schouten JP , Boezen HM . A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population . Am J Respir Crit Care Med . 2005;172:329–333
  40. Burrows B , Bloom JW , Traver GA , Cline MG . The course and prognosis of different forms of chronic airways obstruction in a sample from the general population . N Engl J Med . 1987;317:1309–1314

PII: S0002-9343(06)00923-5

doi: 10.1016/j.amjmed.2006.08.002

The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 4-11 , October 2006

Article Tools

* Image Usage & Resolution